Tranexamic Acid
Overview
Tranexamic Acid is antifibrinolytic agent. Tranexamic Acid is analogue of aminocaproic acid. Chemically Tranexamic Acid is identified as trans-4-(aminomethyl) cyclohexanecarboxylic acid. Tranexamic Acid is effective to reversed the effects of streptokinase or other fibrinolytic activity. It may be used for conditions in which bleeding control is required such as after surgery or injury, recurrent nosebleeds or abnormal vaginal bleeding.
Categories
- 10 Drugs affecting the blood
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Tranexamic Acid's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 250 to 750 mg | 500 (500) | 8 hourly | PO | |
| 0.5 to 1 g | 0.75 (0.75) | 8 hourly | Slow IV | Local fibrinolysis |
Paedriatic Dosage (20kg)
|
| 25 mg/kg | 25 (25) | 8 hourly | Oral | - |
Neonatal Dosage (3kg)
|
| 25 mg/kg | 25 (25) | 8 hourly | Oral | - |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Tranexamic Acid
Back to top
Manufacturers of
Tranexamic Acid
in Pakistan
Back to top
Previous Drug Generic - Next Drug Generic